Interventional Cardiology & Peripheral Vascular Devices Market Analysis

Interventional Cardiology & Peripheral Vascular Devices Market Analysis

In terms of application, the interventional cardiology & peripheral vascular devices market from the congenital heart defect correction segment was valued at over USD 3 billion in 2022. This is attributed to the high burden of atrial septal defects among pediatric patients. Based on statistics from the CDC, nearly 2,118 babies are diagnosed with an atrial septal defect in the U.S. each year. In addition, the prevalence of diabetes mellitus has also increased in developed countries. Since diabetes is a leading cause of congenital heart defects, the use of interventional cardiology devices will surge globally.
 

The interventional cardiology & peripheral vascular devices market share from the ambulatory surgical centers end-use segment is poised to depict over 8% CAGR through 2023-2032, driven by the shifting preference toward minimally invasive procedures. These surgical practices are associated with reduced risks, convenience, and other attributes. The availability of skilled healthcare personnel is also contributing to the growing preference for treatment in ASCs. These factors, alongside the increasing number of patients with heart diseases, will augment the usage of interventional cardiology and peripheral vascular equipment in these centers.
 

North American interventional cardiology & peripheral vascular devices market size is anticipated to surpass USD 13 billion by 2032. The presence of state-of-the-art healthcare facilities for conducting minimally invasive cardiac procedures is among the major growth drivers. In the U.S., the number of elderly people susceptible to chronic diseases has also risen. Furthermore, the rising disposable income and healthcare expenditure are expected to amplify product consumption across the region.